Again nothing to take away from DD. DD is DD. We have known for years HRI has been making $200 Million plus in revenue over the years. It has been known it is a well established Pharmacy Benefits Manager. We have seen discount cards years ago from the old HRI website. We have known that this is tied in to a network of over 60,000-70,000 pharmacies in the country. This is not new information. Now we need to know where is the tie in to Univec. How will this affect Univec in the future? At first I had asked Dr Dalton maybe two years ago if HRI would merge with another PBM for example with Rite Aid, since at the time PBMs were merging left and right and Rite Aid still had yet to do such a merger. I received no response. In that scenario HRI could have been split in an equity partnership/ownership and be flipped onto NASDAQ a new shared company and Univec shareholders would receive shares in this new company. This is what we need now critical thinking. Deeper diving, not just rediscovering old known information. It’s now November 2021 we need info on the direction of the company and how shareholder value will be build. No more conjectures but real facts. Some say when Dr Dalton decides to release it we will know. We should have been given some clear direction the moment we became current in my opinion. It’s now weeks and months later. Sure we can wait and give him time to do what he needs to do but as shareholders we should be at least active participants in some of this. Not just needless buying although most of us have enough shares. It’s beginning to be a bit greedy in a sense. IMHO. Hopefully we won’t be in a scenario where he finally speaks only to say we are pushed into 2022. Have great weekend all, don’t stop the critical thinking on the stock and company, not just hoping and believing.